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Reduction of Langer hans Cells in Human Epidermis during PUV A 
Therapy: A Morphometric Study 
KRISTIAN REE, M.D. 
Institute of Pathology, Electronmicroscopical Laboratory, The National Hospital, Oslo, Norway 
Skin biopsies were obtained before and after PUV A 
therapy from the normal skin of 5 psoriatic patients. By 
electron microscopic morphometric techniques the pre-
treatment volume density ofLangerhans cells within the 
epidermis was estimated to be approximately 1%. This 
density was reduced in all 5 patients after therapy. The 
volume density of Langer hans cell granules per Langer-
hans cell cytoplasm was on an average 0.8% and this 
density was reduced in 4 of the patients after therapy, 
while in one patient there was an increase. There was a 
reduced volume density of Langer hans cell granules per 
unit volume of epidermis in all 5 patients after therapy. 
The mean length of the Langerhans cell disc was 260 ± 
120, nm the mean thickness 40 nm and the mean diameter 
of the Langerhans cell vesicle 120 ± 30 nm. None of these 
parameters changed after PUV A therapy. The reduced 
volume density of Langerhans cells is discussed in the 
context of possible implications for immune reactions in 
the skin. 
Langerhans cells (LC) and lymphocytes (Ly) participate in 
immunological mechanisms of the skin [1,2]. Recent studies 
have demonstrated that PUVA therapy impairs several such 
immunological reactions [3-5]. We considered it to be of interest 
to study this phenomenon further, particularly since it has been 
suggested that an inhibition of immunological mechanisms of 
the skin, may be associated with the reported increase of squa-
mous cell carcinomas after PUV A therapy [3,6-8]. 
In the present study a morphometric electron microscopic 
(EM) technique has been applied. The volume density [9,10] of 
Langerhans cells and lymphocytes of the epidermis has been 
estimated before and after PUV A therapy as well as the volume 
density of LC granules. The mean thickness and length of the 
LC disc and the mean diameter of the LC vesicle has also been 
calculated. 
MATERIALS AND METHODS 
Patients 
Five male caucasian patients (patient E.M., E.B., E.L., O.J . and 
K.H.) with psoriasis vulgaris covering 30-40% of their body surface 
were selected for the study. They all h·ad skin type II-III, had never 
received PUVA therapy before and had been within UV -irradiation for 
at least 3 mo. Before starting PUVA therapy a biopsy from a skin ru·ea 
not clinically involved by psoriasis was taken on the gluteal region 10 
em below the patients left iliac crest. The biopsies were fixed and 
processed for electron microscopy as described below. Screening labo-
ratory tests were examined and found to be normal. 
PUVA Therapy 
The therapy regim~n was in accordance with that used by Wolff et 
al [11] using Sylvania FR 90T12 lamps (Waldmann 4000 whole body 
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irradia tion unit) [12] and 8-methoxypsoralen (Meladinin, Nyco, Oslo). 
The lamps were tested before each treatment with a Waldmann PUVA 
meter [12] giving an exposure time of between 40-60 min to achieve a 
dose of 10 J /cm2. The patients received therapy 3 times a week. Twenty 
minutes after completing a 10 J / cm2 irradiation a posttreatment biopsy 
(skin uninvolved by psoriasis) was taken a t a distance of 2 em fTom the 
pretreatment biopsy. At the time of sampling the patients were just 
clearing of their psoriasis (after 2112- 3 mo therapy) and were about to 
start maintenance therapy. At this time the tota l UV A dosage for 
patient E.M. was 80 J /cm2 , E.B. 66 J /cm2, E.L. 52 J /cm2 , O.J. 107 J / 
cm2 and K.H. 145 J /cm2 • 
Transmission Electron Microscopy 
Lidocaine chloride 2% was injected subcutaneously and a 10 X 5-mm 
boat-shaped biopsy was cut free with a scalpel and forceps and trans-
ferred to 2.5% glutaraldehyde in Soerensen's phosphate buffer (pH 7.3) 
a t room temperature. The biopsies were trimmed and cut perpendicular 
to the skin surface into 2-mm cubes. After 4 hr the biopsies were rinsed 
in Tyrode solution (pH 7.3) 3 times and postfixed at 4 oc for 2 hr in 1% 
osmium tetroxide in Tyrode solution (pH 7.3). The specimens were 
rinsed in Tyrode solution 3 times and dehydrated in graded series of 
ethanol (30% for 15 minutes, 60% for 15 min, 90% for 20 min, and 100% 
for 30 min X 2) and in propylene oxide (30 min x 2). The specimens 
were left over night at 4°C in a 1:1 mixture of propylene oxide/Epon 
(Epon 812, Ladd, Burlington, Vermont) . The mixture was replaced by 
Epon and 4 hr later the specimens were orientated and embedded in 
flat embedding moulds. The blocks were hardened for 3 days at 60°C. 
Silver-gray ultrathin sections were cut with a diamond knife and 
mounted on 75 mesh Formvru· coated copper grids. The sections were 
poststained with uranyl acetate and lead citmte [13] and viewed in a 
J eol100 B transmission electron microscope. 
Morphometry 
From each of the 5 control and test biopsies 3-5 blocks (blocks with 
satisfactory orientation) were chosen for thin sectioning. 2-11m sections 
were cut perpendicular to the skin surface, stained with Toluidine blue 
1%, and examined under the light microscope.. The Langerhans cells 
and lymphocytes are not visible with this staining technique and 
random areas of the epidermis (above a dermal papilla) were. trimmed 
out for thin sectioning. The ultrathin sections included the stratum 
basale, stratum spinosum, stratum granulosum, and s tra tum corneum. 
Each block was sectioned 3-4 times and 50 11111 were trimmed away 
between each ultrathin sectioning and different areas of the epidermis 
sectioned each t ime. From each ultrathin section, one grid (out of 3-5) 
was chosen at random. The first section on the grid observed in the 
electron microscope to be completely unobstructed by grid bru·s was 
photographed part by part at a primary magnification of X 830. The 
negatives were photographically enlarged to X 2500 (Level l) (Fig 1). 
The same section was then systematically surveyed at a primary 
magnification of X 5,000 electron optical (and X 10 optical) . Whenever 
a LC or Ly or cytoplasmic element thereof was observed (for definition 
see below), a photograph was taken a t a primru·y magnifica tion of X 
5,000 (Fig 2 and 3). Thereafter the cell profile was photographed part 
by part at a primary magnification of X 20,000. The negatives (X 5,000 
and X 20,000) were photographically enlru·ged to X 15,000 and X 60,000, 
respectively (Level II) (Fig 4 and 5). By examination of the pictm es at 
Level II (X 60,000) it was determined whether the cell or cell element 
contained (I) LC granules (defined as a LC) or (2) contained no LC 
granules, no premelanosomes or mclanosomes, no tonofilamentous or 
microfilamentous bundles and no desmosomes (defined as a LC con-
taining no LC granule in that particular section ("indeterminate ce ll" ) 
or (3) the nucleus and the cytoplasm had the chru·acteristics of a 
lymphocyte (defined as a Ly) . By the a id of the same cell profile 
pictured at X 15,000, the posit ion of the cell profile on the Level I (X 
2,500) micrograph was established and the outline of the cell element 
encircled with a fine-point felt pen (Fig 1) . 
At Level I a total of 101 micrographs were examined in the overall 
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FIG 1. Part of epidermis fixed after PUVA therapy. Two encircled 
cell elements are seen both of which contained Langer hans cell granules 
on examination at h igher magnification (Fig 4). The encircled cells 
were used for volume density measurements (Table I). Bar= lO f.Lm 
(X 2,500). 
FIG 2. Cell in the epidermis with a pale cytoplasm devoid of tono-
filaments. Higher magnification of encircled cell in Fig 1. Bar = 5 f.Lm 
(X 4 ,200) . 
control group and 129 micrographs in the test. group. The volu me 
density measmements were performed using a coherent double lattice 
test grid [9] with latticed spacing of 0.5 em and with 36 fme point per 
coarse point This spacing gave an expected relative estimation eJTor of 
approximately 2.5% when relating test prints counted to volume dens-
ities (Table I; reference 9, page 263) . The reference space compris~d 
the stratum basale, stratum spinosum, and stratum granulosum and 
was counted with the coarse points. The LC and Ly were counted with 
the fine points. The points counted for each patient are listed in 
parenthesis in Table I. 
At Level II a total of 572 micrographs were examined in the overall 
control group and 209 micrographs in the test group. The reference 
space comprised the cytoplasm of the LC containing LC granules as 
well as the LC not containing granules. The volume density of the LC 
granules was calculated using the same test grid as applied at Level I. 
For obliquely sectioned granules (Fig 4) difficulties sometimes arose as 
to the exact outline of the granule. If in doubt whether the testpoin t 
was lying inside or outside the granule, the testpoint was consistently 
not counted. The expected relative error in estimating volume densities 
of LC granules was on an average less than 2.5% (Table II; reference 9, 
page 263) . The points counted for each patient are listed in parenthesis 
in Table II. 
The maximum thickness and length of the LC disc was measured 
with a ruler and the longest diameter of the LC vesicle measured 
whenever the club-shaped appearance of the LC granule was evident. 
The diameter at right angle to the longest diameter was also measw·ed 
and the mean of the 2 diameters calculated (see Fig 4). The magnifi-
cation of the photomicrographs were estimated using a magnification 
calibration grid. 
The results were statistically analysed using standru·d deviation ru1d 
Wilcoxon's test for paired compru·isons [14). 
A qualitative judgement of the overall morphology of the LC and Ly 
was made before and after PUV A therapy and any changes noted. 
RESULTS 
From Table I it is seen that the volume density of LC was on 
an average 1% before therapy and that this value was reduced 
in all 5 patients after PUV A therapy ( p < 0.05). The posttreat-
ment density was reduced to approximately 5 to 50% of its 
pretreatment level. Cells or cytoplasmic elements that did not 
contain LC granules in the examined sections ("indeterminate 
cells") contributed 13-30% of the total LC volume density. The 
overall majority of this volume density fraction comprised 
agranular cytoplasmic elements, only on very rare occasions 
were agranular cells sectioned through the nucleus (Fig 3 and 
5). The measurements for Ly were inconclusive as only 3 
patients exnibited Ly in the pretreatment group. It is to be 
noted, however, that none of the 5 patients exhibited Ly after 
therapy. 
From Table II it is seen that in 4 of the patients the post-
treatment volume density of LC granules per LC was reduced 
to approximately 20 to 80% of its pretreatment level. For one 
patient the volume density increased by ·approximately 30% (p 
> 0.05). Comparing the points counted for the LC granules 
(Table II) with the points counted for the epidermal (Ep) 
reference space (Table I), it is evident that there was a reduction 
in LC granules per unit volume of epidermis in all 5 patients 
after PUVA therapy (p < 0.05). 
From Table III it is seen that the mean length of the LC disc 
was 260 ± 120 nm, the mean thickness 40 nm and the mean 
FIG 3. Cell in the epidermis with a pale cytoplasm devoid of t.ono-
ftlaments. Bar= 5 f.Lm (X 4,200). 
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FIG 4. Cytoplasm of a Langerhans cell showing numerous Langerhans cell granules. The lines with arrowheads indicate granules that were 
used for length , thickness, and diameter measurements (Table III) . For volume density measurements the obliquely sectioned granules (G) were 
a lso coun ted (Ta ble II). Nucleus (N). Neighbouring kerat inocyte (K). H igher magnification of box in Fig 2. Bar= 0.5 p.m (X 60,000) . 
FIG 5. Cytoplasm of a Langerhans cell containing no Langerhans cell granules in this particular section. The cytoplasm was included in 
volume density measurements of Langerhans cell granules. Nucleus (N) . Neighbow·ing keratinocyte (K) . Higher magnification of box in Fig 3. 
Bar= 0.5 p.m (X 60,000). 
June 1982 REDUCTION OF LANGERHANS CELLS DURING PUVA 491 
T ABLE I. Volume density of La.ngerhans cells (LC) and lymphocytes (Ly) as a. percentage of the total epidermis (Ep) before and after PUVA 
therapy in 5 patients 
Patient E.M. Patient E. B. Patient E.L. Patient O .• J. PatienL K.H. 
Before After Before After Before Aft.er Before After Befo•·e After 
PUVA PUVA PU VA PUVA PUVA PUVA PUVA PUVA PUVA PUVA 
Ep (10728) (17424) (15408) (13932) (13608) (11 052) (20232) (26064) (7380) (9324) 
100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 
LC containing (110) (90) (130) (33) (15B) (28) (109) (l) (63) (30) 
granules 1.03% 0.52% 0.84% 0.24% 1.17% 0.25% 0.54% 0.004% 0.85% 0.32% 
LC not contain- (19) (6) (20) (25) (31) (7) (49) (7) (14) (19) 
ing granules 0.1 8% 0.03% 0.13% 0.18% 0.23% 0.06% 0.24% 0.03% 0.19% 0.20% 
Total density (1 29) (96) (150) (58) (1 90) (35) (1 58) (8) (77) (49) 
LC 1.21% 0.55% 0.97% 0.42% 1.40% 0.31 % 0.78% 0.034% 1.04% 0.52% 
Total density (1 4) (0) (0) (0) (9) (0) (2) (0) (0) (0) 
Ly 0.13% 0% 0% 0% 0.07% 0% 0.01 % 0% 0% 0% 
The analysis was performed on electron micrographs at a magnification of x 2,500. 
The actual reference points used in the calculations are listed in parentheses. 
TABLE II. Volume density of La.ngerhans cell granules (LC gran) as a. percentage of the cytoplasm of the La.ngerhans cells (cyt L C) before 
and after P UVA therapy in 5 patients 
Patient E.M. Patient E. B. Patient E.L. Patient O.J. Patient K.H. 
Before After Before After Before After Before After Before After 
PUVA PUVA PUVA PUVA PUVA PUVA PUVA PUVA PUVA PuVA 
Cyt LC containing (44028) (38052) (52092) (211 68) (78156) (8460) (57960) (360) (31392) (11880) 
granules 
Cyt LC not con- (8172) (3944) (7560) (124 28) (19044) (2340) (23112) (3024) (9144) (8136) 
taining granules 
Cyt lymphocytes (4644) (0) (0) (0) (2268) (0) (216) (0) (0) (0) 
Total cyt LC (52200) (41996) (59652) (33588) (97200) (10800) (81072) (3384) (40536) (20016) 
100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 
LCs gran (418) (412) (405) (46) (1319) (116) (353) (6) (363) (106) 
0.80% 0.98% 0.68% 014% 1.36% 1.07% 0.44% 0.18% 0.90% 0.53% 
The cytoplasmic volume of the Langerhans cells (Total cyt LC) comprise the sum of the cytoplasm of the Langerhans cells containing LC granules and the 
Langerhans cells not containing LC granules. 
The analysis was performed on electron micrographs at a magnification of X 60,000. 
The actual reference points used in the calculations are listed in parentheses. 
TABLE III. 1\1ean leng th and thickness of the Langerhans cell disc (LC disc) and mean diameter of the Langerha.ns cell vesicle (LC vesicle) 
before and after P UV A thempy 
Patient E.M. Patient E.B. Patient E.L. Patient O.J . Patient K.H. 
M ean length (nm) of LC disc 
Before PUVA 300 ± 140 220 ± 70 250 ± llO 290 ± 130 270 ± 120 
After PUVA 270 ± 100 240 ± 90 230 ± 100 210 ± 100 230 ± 120 
M ean th ickness (nm) of LC disc 
Before PUVA 40 40 40 40 40 
After PUVA 40 40 40 40 40 
M ean diameter (nm) of LC vesicle 
Before PUVA 110 ± 20 130 ± 30 140 ± 30 120 ± 30 130 ± 40 
After PUVA 120 ± 30 120 ± 5 120 ± 30 120 ± 40 
The measm ements for mean length and mean thickness is in each case based upon from 47 to 297 single measmements. The mean diam eter 
is in each case based upon ti·om 10 to 98 single measurements. 
Analysis performed on electron micrographs at a magnification of X 60,000. 
diameter of the LC vesicle 120 ± 30 run. N either of these 
parameters ch a nged after PUVA therapy. 
The overall morphology of the LC were unaltered after 
therapy. Before th erapy t h ere was always an abundance of LC 
granules whenever th e cell was sectioned throu gh t h e Golgi 
region, and the same was seen after therapy. Ther e was no 
increase in autoph agosomes or oth er sign s of degen erative 
c h anges. LC were on very rare occasions observed in the up-
permost parts of t h e dermis both before a nd after therapy. 
DISCUSSION 
The m eth odological design presen ted in this study h as e na -
bled a quantitative a nalysis of stru ctW'es which are infl·equently 
e n countered and where a combined use of low and high power 
magnification is necessary for the purpose of identification or 
analysis. An effort to further increase t h e precision of counting 
the microscopic featW'es would in this case yield very little as 
the biological variation between individuals determines th e 
overall efficien cy [10]. 
We obtained lower values for the normal n·equency of LC 
(average 1%) than reported using differen t techniques (2-4%) 
[15,16]. This difference h as several explanations: (1) The fact 
t h at the stratum granulosum has been included as a reference 
s pace. (2) The intercellular space is included. (3) The sections 
are cu t perpendicular to the skin surface. Randomly orientated 
bloc ks [15] would give a greater y ie ld of LC. (4) The density of 
LC is known to vru·y from one anatomical r egion to another. 
The term " indeterminate cell" h as previously been applied 
to the cell population in the epidermis th at do not contain 
specific ultrastructural mru-kers [17]. Serial sections h ave 
shown, however, that the majority of "indeterminate cells" 
con tain LC granules when sectioned tlu·ough [18]. Our own 
studies with serial sections ru·e in accordance with th ese find-
ings, and we h a ve consequently d esignated these cells for LC. 
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Nevertheless, it is difficult to conclusively establish that all of 
these cells contain LC granules. 
Previous reports have described the effect UV -light has on 
the LC of the epidermis [ 4,15,19,20]. The work of Aberer et al 
[20] is of particular interest as a conjoint use of histochemical, 
immunofluorescent and EM techniques were applied. They 
found a substantial decrease in adenosine-triphosphatase 
(ATPase) and Ia bearing cells after UV-light exposure which 
was not parallelled with an equal decrease in ultrastructurally 
defined LC. They concluded that the discrepancy probably was 
due to a loss of LC surface characteristics, but not necessarily 
to a depletion of the LC themselves. The assessment of ultra-
structurally defined LC was based upon a qualitative judge-
ment, a quantitative method as outlined in the present study 
was not applied. 
The effect of PUV A therapy on LC has been studied with 
the ATPase technique [21,22]. Few, but big and bizarre LC 
were found after therapy. Our present EM study confrrms that 
there is an actual depletion of LC. 
How can the reduction of LC observed in the present study 
be explained? We did not observe autolytic LC in the epidermis 
and no increase or decrease of LC in the uppermost parts of the 
dermis. Our data consequently does not permit any qualified 
suggestions on whether the cells die and disappear through 
sloughing off in the stratum corneum or move out into the 
dermis. Possibly the events take place early during PUV A 
therapy. The population of LC observed in the present study 
seems to have adopted in some way to the therapy. 
The function and origin of LC granules is unknown and 
conflicting theories have been presented [18,23,24]. The present 
study shows that the shape of the granules are unaffected by 
PUV A therapy.' The reduced volume density of LC granules 
found in 4 of the 5 patients does not reach statistical signifi-
cance. 
One theory regarding tumor defense mechanisms imply that 
mutated or otherwise malignantly transformed cells arise fre-
quently in the body and that these cells are recognized by the 
immune surveillance system and destroyed (Review [25]). If 
such a system exists in the epidermis one may speculate on 
whether the reduced volume density of LC observed after 
PUV A therapy may have implications in this context. 
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